Nuclear receptor NR4A1 is a tumor suppressor down-regulated in triple-negative breast cancer.

Oncotarget · 2017 · PMC5589587 · PMID 28903348

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an obvious trendno p-value reported

Finally, the patients with low NR4A1 tumors showed an obvious trend of worse overall survival than the patients with high NR4A1 tumors (data now shown), but the difference in overall survival time between these two patient groups did not reach a statistically significant level ( p = 0.1285 by Gehan-Breslow-Wilcoxon test).

also in 1,006 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.